The effect of maternal Tdap vaccination on infant immunologic responses to routine pediatric vaccines is unknown.
This was a cohort study of infants whose mothers received or did not receive Tdap vaccine during pregnancy. Maternal and cord blood samples were collected at delivery; infant blood samples collected before and after primary series and booster dose of DTaP and other vaccines. Geometric mean antibody concentrations or titers to pertussis, hepatitis B, tetanus, diphtheria, H. influenzae type b, and polio antigens were measured. Mean maternal-to-cord blood antibody ratios were calculated.
At delivery, maternal and cord antibody concentrations to pertussis antigens were higher in the Tdap group (n=16) than control group (n=54; maternal: 1.9 to 20.4-fold greater; cord: 2.7 to 35.5-fold greater). Increased antibody concentrations persisted for infants at first DTaP (3.2 to 22.8-fold greater). After primary series, antibody concentrations to pertussis antigens were lower in Tdap group (0.7 to 0.8-fold lower), except for FIM (1.5-fold greater). Antibody concentrations to pertussis antigens before and after booster dose were comparable (pre-booster: Tdap group 1.0 to 1.2-fold higher than controls; post-booster: 0.9 to 1.0-fold lower). Differences in FIM values at these time points are difficult to interpret, due to varying FIM content among DTaP vaccines administered to infants in both groups.
Maternal Tdap immunization resulted in higher pertussis antibody concentrations during the period between birth and the first vaccine dose. Although slightly decreased immune responses following the primary series were seen compared with controls, differences did not persist following the booster.
Journal:Pediatr Infect Dis J. 2013